Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Kuhnke

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|January 30, 2019
Mechanistic Reactivity Descriptors for the Prediction of Ames Mutagenicity of Primary Aromatic AminesLara Kuhnke, Antonius Ter Laak, Andreas H Göller
Molecules (Basel, Switzerland)|December 28, 2019
Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional NetworksFloriane Montanari, Lara Kuhnke, Antonius Ter Laak, et al.
Journal of Medicinal Chemistry|February 8, 2023
Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound CollectionDaniel H O' Donovan, Claudia De Fusco, Lara Kuhnke, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2021
Machine Learning Applied to the Modeling of Pharmacological and ADMET EndpointsAndreas H Göller, Lara Kuhnke, Antonius Ter Laak, et al.
Drug Discovery Today|July 12, 2020
Bayer's in silico ADMET platform: a journey of machine learning over the past two decadesAndreas H Göller, Lara Kuhnke, Floriane Montanari, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|January 30, 2019
Mechanistic Reactivity Descriptors for the Prediction of Ames Mutagenicity of Primary Aromatic AminesLara Kuhnke, Antonius Ter Laak, Andreas H Göller
Molecules (Basel, Switzerland)|December 28, 2019
Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional NetworksFloriane Montanari, Lara Kuhnke, Antonius Ter Laak, et al.
Journal of Medicinal Chemistry|February 8, 2023
Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound CollectionDaniel H O' Donovan, Claudia De Fusco, Lara Kuhnke, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2021
Machine Learning Applied to the Modeling of Pharmacological and ADMET EndpointsAndreas H Göller, Lara Kuhnke, Antonius Ter Laak, et al.
Drug Discovery Today|July 12, 2020
Bayer's in silico ADMET platform: a journey of machine learning over the past two decadesAndreas H Göller, Lara Kuhnke, Floriane Montanari, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.
Pageof 1